|
|
|
| Webinar: Enhanced biotherapeutic protein expression using advanced vector systems | In recombinant protein manufacturing with GS-CHO cells, vector design at transfection sets the stage for titre, quality, and long-term stability. In this webinar, Lonza introduces GSquad® Pro, its next-generation expression vector platform featuring the high-performance LHP-1 promoter. Discover how data-driven insights into gene expression control are advancing CHO vector design, accelerating development timelines, and strengthening key biomanufacturing performance metrics. Click here to learn more. |
|
|
|
| Driving Robust Tech Transfer In Biologics | Webinar | Samsung Biologics | Computational Fluid Dynamics simulation is essential for biologics tech transfer. See how this predictive tool optimizes critical scale-up processes, reducing risk and expediting time to market. |
|
|
|
| Scaling With The Client In Mind | White Paper | By Maeve McQuade, August Bioservices | In today’s fast-moving biopharma landscape, scaling from clinic to commercial takes more than expertise. Uncover how collaboration can transform and drive confident progress. |
|
|
|
|
By Louis Garguilo, chief editor, Outsourced Pharma | After graduating with a biology degree from Howard University and entering the pharma industry, Stephanie Wimberly found herself the only woman — the only black woman — in a manufacturing facility in Maryland. A supervisor made it clear he didn’t want her on his team; she was reassigned to the night shift at her facility. “I had a family to support, and night shift, or abuse, was not what I signed up for,” she says. “But I didn’t have many options.” Here is how she persevered, and prospered. | |
|
|
|
INDUSTRY INSIGHTS CONTINUED |
|
|
|
|
|
| CDMO Or No CDMO... That Is The Question | Article | Cytiva | Success depends on internal capabilities and knowing when outsourcing can accelerate timelines. Assimilate how decisions reduce risk, avoid costly delays, and keep your organization competitive. |
|
|
|
| Improve Scalability And Manufacturability | Article | By Carmen Juds, Ph.D., Lonza | Learn about the process conditions and protocols that were chosen as optimization targets and the resulting improvements to ADC production and purification that assessing these parameters provided. |
|
|
|
|
|
| Explore 20+ new CDMO presenters in quick 20-minute sessions during the Outsourced Pharma Capabilities Update. Sessions include Analytical Services, ADC, Large and Small Molecules, Cell and Gene Therapy, and Fill/Finish. Each session offers a quick, informative look at capabilities to help you find the best-fit partner. Registration and on-demand access are all free! Click here to learn more. |
|
|
|
|
|
Microbial Capabilities | AGC Biologics | We offer end-to-end microbial services, including cell line development, process development, scale-up, and both clinical and commercial GMP manufacturing. |
|
|
Robotic Pharmaceutical Labeling Cell System | HERMA | With the robot-assisted labeling cell system, view how challenges in wrap-around labeling of label material can be solved more effectively. Discover the advantages here. |
|
|
Sterile Fill/Finish Capability | Upperton Pharma Solutions | Through extensive experience in product development, our team can support you with aseptic and terminally sterilized small volume liquids, as well as ocular and pulmonary delivery. |
|
|
OUTSOURCED PHARMA CAPABILITIES UPDATE |
|
|
|
CDMOs in biologics, cell and gene, and small molecule share their capabilities and available capabilities. See for yourself why this virtual event has become a wildly popular resource to identify options for your development and manufacturing needs. |
|
|
| Connect With Outsourced Pharma: |
|
|
|
